Skip to content

Bill Tracking

Tracking Status Report Antonio Ciaccia
Tracking group: OPA Legislation Tracker

DEXTROMETHORPHAN SALES

To prohibit sales of dextromethorphan without a prescription to persons under age 18.
Text/Analysis
Committee Hearing in Senate Local Government, Public Safety & Veterans Affairs (5/20/2020; CONTINUED (No testimony))

VETERAN HEALTH CARE

To require certain entities to inform veterans about health care benefits available to all veterans.
Text/Analysis
Introduced and Referred in House (2/12/2019; Armed Services & Veterans Affairs)

DRUG INFORMATION

Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text/Analysis
Committee Hearing in House Health (6/4/2019; REPORTED (No testimony))

IMMUNIZATIONS

Regarding notice of school child immunization requirements and exemptions.
Text/Analysis
Committee Hearing in House Primary & Secondary Education (4/2/2019; CONTINUED)

HB 166

(Enacted)
STATE BUDGET

To make operating appropriations for the biennium beginning July 1, 2019, and ending June 30, 2021, and to provide authorization and conditions for the operation of state programs.
Text/Analysis
Signed by the Governor (7/18/2019; Signed: July 18, 2019 with vetoes; Delivered to the governor July 17, 2019)

DENTAL FACILITIES

To specify requirements for the operation of mobile dental facilities.
Text/Analysis
Passed in Senate (5/20/2020; 32-0)

PRESCRIPTION READERS

Regarding prescription drug readers for visually impaired patients.
Text/Analysis
Committee Hearing in House Health (1/21/2020; CONTINUED)

VACCINATIONS

To enact the "Medical Consumer Protection Act" to prohibit an employer from taking an adverse employment action against a person who has not been or will not be vaccinated.
Text/Analysis
Referred in House (6/4/2019; Commerce & Labor)

HEALTH CARE

To establish and operate the Ohio Health Care Plan to provide universal health care coverage to all Ohio residents.
Text/Analysis
Committee Hearing in House Health (9/10/2019; CONTINUED (See separate story))

ADDICTION TREATMENT

Regarding the administration of addiction treatment drugs and federal agency access to the Ohio Automated Rx Reporting System.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (6/9/2020)

INSULIN COST REPORT

To require the Attorney General to investigate insulin pricing and prepare and submit a report.
Text/Analysis
Committee Hearing in House Health (2/11/2020; CONTINUED)

INSULIN COST-SHARING

To cap cost-sharing for prescription insulin drugs.
Text/Analysis
Committee Hearing in House Health (2/18/2020; CONTINUED)

PHARMACY BENEFIT MANAGERS

To impose requirements on pharmacy benefit managers.
Text/Analysis
Committee Hearing in House Health (1/14/2020; CONTINUED (See separate story))

DISEASE COUNCIL

To establish the Rare Disease Advisory Council.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (6/9/2020)

MEDICATION SWITCHING

Regarding prescription drugs and medication switching.
Text/Analysis
Committee Hearing in House Health (2/4/2020; CONTINUED)

EMERGENCY PRESCRIPTIONS

To increase the frequency at which a pharmacist may refill certain prescriptions on an emergency basis and to require health benefit plans to cover drugs dispensed in those situations.
Text/Analysis
Committee Hearing in House Health (1/21/2020; CONTINUED)

OCCUPATIONAL LICENSING

To require an occupational licensing authority to issue a license or government certification to an applicant who holds a license, government certification, or private certification or has satisfactory work experience in another state under certain circumstances.
Text/Analysis
Committee Hearing in House State & Local Government (1/29/2020; CONTINUED)

MEDICAID MANAGED CARE

To require Medicaid managed care organizations to engage in a competitive selection process when contracting with a laboratory services provider vendor.
Text/Analysis
Committee Hearing in House Health (2/18/2020; CONTINUED)

HEALTH INSURANCE

To prohibit certain health insurance cost-sharing practices.
Text/Analysis
Committee Hearing in House Health (6/2/2020; CONTINUED (See separate story))

DRUG PRICING

To prohibit a pharmacy benefit manager from taking certain actions with respect to reimbursements made to health care providers that participate in the federal 340B Drug Pricing Program.
Text/Analysis
Committee Hearing in House Health (6/2/2020)

CIVIL IMMUNITY

To grant civil immunity to a person who provides services for essential businesses and operations for injury, death, or loss that was caused by the transmission of COVID-19 during the period of emergency declared by Executive Order 2020-01D, issued on March 9, 2020, and to declare an emergency.
Text/Analysis
Referred in Senate (6/3/2020; Judiciary)

BUSINESS PRACTICES

Regarding the operation of businesses, practice of certain professions, and completion of education as it relates to COVID-19 and to declare an emergency.
Text/Analysis
Committee Hearing in House State & Local Government (6/3/2020; CONTINUED (See separate story))

TELEHEALTH

To establish and modify requirements regarding the provision of telehealth services and to declare an emergency.
Text/Analysis
Committee Hearing in House Insurance (6/3/2020; CONTINUED)

CLAIM INFORMATION

To require health plan issuers to release certain claim information to group plan policyholders and to allow a professional employer organization to file federal payroll taxes entirely under a client employer's tax identification number.
Text/Analysis
Committee Hearing in Conference Committee on SB 9 (6/2/2020--Canceled)

DRUG INFORMATION

Regarding pharmacy benefit managers, pharmacists, and the disclosure to patients of drug price information.
Text/Analysis
Committee Hearing in Senate Insurance & Financial Institutions (4/3/2019; CONTINUED)

CONTROLLED SUBSTANCES

Regarding the disposal of controlled substances.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (4/10/2019; CONTINUED)

SB 24

(Enacted)
ALZHEIMER'S DISEASE

To establish the Alzheimer's Disease and Related Dementias Task Force.
Text/Analysis
Signed by the Governor (11/6/2019; Signed: November 6, 2019; Effective: in 90 days)

MEDICAID COPAYMENTS

Regarding Medicaid copayment requirements.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (2/19/2019; CONTINUED)

DRUG PRESCRIBING

Regarding non-opioid directives and non-opioid therapies.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (5/1/2019; CONTINUED)

SB 57

(Enacted)
HEMP

to establish conditions and requirements governing the regulation of hemp and hemp products, to amend the version of section 109.572 that is scheduled to take effect on September 20, 2019, and the versions of sections 3719.01, 3719.41, and 4729.01 of the Revised Code that are scheduled to take effect on March 22, 2020, to continue the provisions of this act on and after those dates, and to declare an emergency.
Text/Analysis
Signed by the Governor (7/30/2019; Signed: July 30, 2019)

NALOXONE DISPENSING

To require the State Board of Pharmacy to educate license holders about the law authorizing naloxone dispensing without a prescription.
Text/Analysis
Committee Hearing in House Health (6/2/2020; REPORTED)

CULTURAL COMPETENCY

To require certain health care professionals to complete instruction in cultural competency.
Text/Analysis
Committee Hearing in Senate Health, Human Services & Medicaid (4/10/2019; CONTINUED)

HEALTH SERVICES

Regarding the provision of cost estimates for scheduled health care services and health care services requiring insurer preauthorization.
Text/Analysis
Committee Hearing in House Health (5/19/2020; CONTINUED)

SEXUAL CONTACT

To prohibit unlawful sexual contact between health care professionals and patients and to revoke professional licenses for criminal misconduct.
Text/Analysis
Committee Hearing in Senate Judiciary (10/2/2019; CONTINUED)

FLU SHOTS

Regarding the authority of podiatrists to administer influenza vaccinations.
Text/Analysis
Committee Hearing in House Health (6/2/2020; CONTINUED)

NETWORK CARE

Regarding out-of-network care.
Text/Analysis
Committee Hearing in Senate Insurance & Financial Institutions (12/11/2019; CONTINUED (See separate story))

INSULIN COST REPORT

To require the Attorney General to investigate insulin pricing and prepare and submit a report.
Text/Analysis
Committee Hearing in Senate Finance: Health & Medicaid Sub. (2/25/2020; CONTINUED)

INSULIN COST-SHARING

To cap cost-sharing for prescription insulin drugs.
Text/Analysis
Committee Hearing in Senate Finance: Health & Medicaid Sub. (2/25/2020; CONTINUED)

OCCUPATIONAL LICENSING

To require an occupational licensing authority to issue a license or government certification to an applicant who holds a license, government certification, or private certification or has satisfactory work experience in another state under certain circumstances.
Text/Analysis
Committee Hearing in Senate General Government & Agency Review (2/19/2020; CONTINUED)

DRUG TREATMENT

To prohibit "fail first" coverage of drugs used to treat stage four advanced metastatic cancer.
Text/Analysis
Passed in Senate (6/3/2020; 33-0)

DRUG PRICING

To prohibit a pharmacy benefit manager from taking certain actions with respect to reimbursements made to health care providers that participate in the federal 340B Drug Pricing Program.
Text/Analysis
Committee Hearing in Senate Finance (2/25/2020; CONTINUED)

PHARMACIST AGREEMENTS

Regarding pharmacist consult agreements.
Text/Analysis
Committee Hearing in House Health (6/2/2020)

TELEMEDICINE

To require health plan issuers to cover telemedicine services during a state of emergency and to declare an emergency.
Text/Analysis
Committee Hearing in Senate Insurance & Financial Institutions (5/27/2020; CONTINUED)

CIVIL IMMUNITY

To revise the law governing immunity from civil liability and professional discipline for health care providers during disasters or emergencies, to provide qualified civil immunity to service providers providing services during and after a government-declared disaster, and to declare an emergency.
Text/Analysis
Passed in Senate Judiciary (6/3/2020; Bill: 24-9; Emergency: 25-8 (Earlier: REPORTED-SUBSTITUTE-AMENDED))

Share

View